サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1597292

ランセットの世界市場の評価：製品別、用途別、年齢層別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Lancets Market Assessment, By Product, By Application, By Age Group, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 234 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ランセットの世界市場の評価：製品別、用途別、年齢層別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
出版日: 2024年11月26日
発行: Market Xcel - Markets and Data
ページ情報: 英文 234 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のランセットの市場規模は、2023年の21億米ドルから2031年年に42億6,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで9.24%の成長が見込まれます。市場は、糖尿病や貧血、白血病などの血液疾患の有病率の増加や、定期的な健康診断に関連する意識の高まり、技術の進歩、政府の取り組みによって着実に成長しています。ランセットは、かかと、耳たぶ、指などの皮膚の一部から毛細血管の血液サンプルを採取するために使用される、小型で携帯可能な医療機器です。その起源は採血にあり、ランセットの歴史は数千年に及び、その後さまざまな医療のニーズに応えるために進化してきました。ランセットは現在、貧血診断に向けたヘモグロビンの評価、糖尿病患者に向けたグルコースの評価、血液凝固障害に向けた凝固の評価に不可欠です。ランセットはグルコース検査で、特に糖尿病患者の血糖値を追跡するために血液サンプルの採取に使用されます。

ランセットは、ヘモグロビンレベルを決定するヘモグロビン検査で使用され、献血者の適格性を評価するために頻繁に使用されます。ランセットは、血液サンプルの採取や血液凝固能の測定に役立つ凝固検査に使用されます。自己モニタリング機器に対する需要の高まりと、痛みの少ない技術の開発によって成長が見込まれるため、ランセット産業の将来は明るいです。一方、ランセット市場は、持続グルコースモニタリング（CGM）のような非侵襲機器の導入によって影響を受ける可能性があります。CGMシステムは、血糖値をモニタリングする伝統的な指先穿刺技術の代わりに、便利で使いやすく、苦痛のないものを提供するため、臨床現場でますます使用されるようになってきています。2023年に、血糖モニター、ケトン体測定器、検査ストリップ、ランセットを含む4つのGlucoRxの計測器が新しい委託推奨に記載されました。GlucoRxの機器は、GlucoRx HCT、GlucoRx Q、GlucoRx Nexus Blue、GlucoRx KEYAです。厳格な審査手順により、最高品質で費用対効果の高い機器のみが認証されることが保証され、提案された計測器、ストリップ、ランセットはこれに合格しました。

当レポートでは、世界のランセット市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のランセット市場の見通し（2017年～2031年）

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェアの分析と予測
    • 製品別
    • 用途別
    • 年齢層別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
  • 市場マップ分析（2023年）
    • 製品別
    • 用途別
    • 年齢層別
    • エンドユーザー別
    • 地域別

第5章 北米のランセット市場の見通し（2017年～2031年）

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェアの分析と予測
    • 製品別
    • 用途別
    • 年齢層別
    • エンドユーザー別
    • シェア：国別
  • 各国の市場の評価
    • 米国のランセット市場の見通し（2017年～2031年）
    • カナダ
    • メキシコ

第6章 欧州のランセット市場の見通し（2017年～2031年）

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • ポーランド

第7章 アジア太平洋のランセット市場の見通し（2017年～2031年）

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第8章 南米のランセット市場の見通し（2017年～2031年）

  • ブラジル
  • アルゼンチン

第9章 中東・アフリカのランセット市場の見通し（2017年～2031年）

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • イスラエル

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

  • 市場促進要因
  • 市場の課題

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

  • 臨床試験
  • 規制当局の承認

第18章 特許情勢

第19章 ケーススタディ

第20章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • HTL-Strefa S.A.
    • Terumo Medical Corporation
    • Becton Dickinson and Company
    • F.Hoffman-La Roche AG
    • B.Braun SE
    • Abbott Laboratories
    • Owen Mumford Ltd.
    • Arkray Inc
    • Bayer AG
    • Medline Industries, LP

第21章 戦略的推奨

第22章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Lancets Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Lancets Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 6. Global Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Lancets Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Lancets Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Lancets Market Share (%), By Application, 2017-2031F
  • Figure 12. North America Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 13. North America Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Lancets Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Lancets Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Lancets Market Share (%), By Application, 2017-2031F
  • Figure 19. United States Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 20. United States Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Lancets Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Lancets Market Share (%), By Application, 2017-2031F
  • Figure 25. Canada Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 26. Canada Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Lancets Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Lancets Market Share (%), By Application, 2017-2031F
  • Figure 31. Mexico Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 32. Mexico Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Lancets Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Lancets Market Share (%), By Application, 2017-2031F
  • Figure 37. Europe Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 38. Europe Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Lancets Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Lancets Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Lancets Market Share (%), By Application, 2017-2031F
  • Figure 44. Germany Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 45. Germany Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Lancets Market Share (%), By Product, 2017-2031F
  • Figure 49. France Lancets Market Share (%), By Application, 2017-2031F
  • Figure 50. France Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 51. France Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Lancets Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Lancets Market Share (%), By Application, 2017-2031F
  • Figure 56. Italy Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 57. Italy Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Lancets Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Lancets Market Share (%), By Application, 2017-2031F
  • Figure 62. United Kingdom Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 63. United Kingdom Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 68. Russia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 69. Russia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Lancets Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Lancets Market Share (%), By Application, 2017-2031F
  • Figure 74. Netherlands Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 75. Netherlands Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Lancets Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Lancets Market Share (%), By Application, 2017-2031F
  • Figure 80. Spain Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 81. Spain Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Lancets Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Lancets Market Share (%), By Application, 2017-2031F
  • Figure 86. Turkey Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 87. Turkey Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Lancets Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Lancets Market Share (%), By Application, 2017-2031F
  • Figure 92. Poland Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 93. Poland Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Lancets Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Lancets Market Share (%), By Application, 2017-2031F
  • Figure 98. South America Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 99. South America Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Lancets Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Lancets Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Lancets Market Share (%), By Application, 2017-2031F
  • Figure 105. Brazil Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 106. Brazil Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Lancets Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Lancets Market Share (%), By Application, 2017-2031F
  • Figure 111. Argentina Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 112. Argentina Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Lancets Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Lancets Market Share (%), By Application, 2017-2031F
  • Figure 117. Asia-Pacific Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 118. Asia-Pacific Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Lancets Market Share (%), By Country, 2017-2031F
  • Figure 120. India Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Lancets Market Share (%), By Product, 2017-2031F
  • Figure 123. India Lancets Market Share (%), By Application, 2017-2031F
  • Figure 124. India Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 125. India Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Lancets Market Share (%), By Product, 2017-2031F
  • Figure 129. China Lancets Market Share (%), By Application, 2017-2031F
  • Figure 130. China Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 131. China Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Lancets Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Lancets Market Share (%), By Application, 2017-2031F
  • Figure 136. Japan Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 137. Japan Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 142. Australia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 143. Australia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Lancets Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Lancets Market Share (%), By Application, 2017-2031F
  • Figure 148. Vietnam Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 149. Vietnam Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Lancets Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Lancets Market Share (%), By Application, 2017-2031F
  • Figure 154. South Korea Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 155. South Korea Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 160. Indonesia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 161. Indonesia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Lancets Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Lancets Market Share (%), By Application, 2017-2031F
  • Figure 166. Philippines Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 167. Philippines Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Lancets Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Lancets Market Share (%), By Application, 2017-2031F
  • Figure 172. Middle East & Africa Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 173. Middle East & Africa Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Lancets Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 179. Saudi Arabia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 180. Saudi Arabia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Lancets Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Lancets Market Share (%), By Application, 2017-2031F
  • Figure 185. UAE Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 186. UAE Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Lancets Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Lancets Market Share (%), By Application, 2017-2031F
  • Figure 191. South Africa Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 192. South Africa Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX12289

Global lancets market is projected to witness a CAGR of 9.24% during the forecast period 2024-2031F, growing from USD 2.10 billion in 2023 to USD 4.26 billion in 2031F. The lancets market is steadily growing due to the increasing prevalence of diabetes and hematologic disorders such as diabetes, anemia, and leukemia, as well as increasing awareness related to regular health checkups, technological advancements, and government initiatives. Lancets are tiny, portable medical devices that are used to take capillary blood samples from parts of the skin, such as the heels, earlobes, and fingers. With their origins in bloodletting, the history of lancets spans thousands of years, and they have since evolved to serve various healthcare needs. Lancets are now essential for evaluating hemoglobin for diagnosing anemia, glucose for diabetics, and coagulation for blood clotting problems. Lancets are used in glucose testing to draw blood samples to track blood glucose levels, particularly in diabetic patients.

Lancets are used in hemoglobin testing, which determines hemoglobin levels, and are frequently used to assess blood donors' eligibility. Lancets are used in coagulation testing to help draw blood samples and measure the blood's clotting capacity. With expected growth spurred by rising demand for self-monitoring devices and developments in low-pain technologies, the lancet industry has a bright future. On the other hand, the market for lancets may be impacted by the introduction of non-invasive equipment like continuous glucose monitoring (CGM). CGM systems are becoming increasingly used in clinical practice because they offer a convenient, easy-to-use, and painless substitute for traditional fingerstick techniques of monitoring blood sugar levels. In 2023, four GlucoRx meters were listed on new commissioning recommendations, including blood glucose monitors, ketone meters, testing strips, and lancets. The devices by GlucoRx that have been included are GlucoRx HCT, GlucoRx Q, GlucoRx Nexus Blue, and GlucoRx KEYA. A stringent review procedure ensured that only the highest-quality and cost-effective devices were certified, and the suggested meters, strips, and lancets passed it.

Increasing Prevalence of Chronic Diseases Drives Market Growth

The increasing prevalence of chronic diseases such as diabetes and blood disorders like anemia is significantly driving the market growth for lancets. Chronic diseases are ongoing, generally incurable illnesses or conditions, such as heart disease, asthma, diabetes, and blood disorders. These diseases can be prevented and managed through early detection, improved diet, exercise, and treatment therapy. Diabetes is at the center of several diseases for multiple long-term conditions and is directly or indirectly related to several other chronic conditions. As per the IDF Diabetes Atlas, in 2021, 1 out of 10 people (or 537 million people) had diabetes. By 2030, the number of people with diabetes is expected to reach 643 million and 738 million by 2045. Anemia has a significant impact on patient outcomes and is prevalent in people with diabetes and chronic kidney disease (CKD). The necessity of frequent blood sampling drives the demand and market expansion for lancets due to the requirement for ongoing monitoring and management of these illnesses.

Government Initiatives Positively Impact Market Demand

Government initiatives are significantly driving the demand for lancets. In many countries, governments are initiating efforts to improve healthcare service delivery and encourage the use of self-monitoring gadgets, hence increasing the need for lancets. Such an example can be found in the case of India, where the Union Health Ministry embarked on a process aimed at screening seventy-five million individuals suffering from hypertension or type II diabetes for necessary treatment by 2025. At the same time, the European Commission is currently working on the promotion of harmonized systems for diabetes care span across 25 provinces, including rural areas. This campaign has increased knowledge concerning routine monitoring of blood sugars; hence, there is a noticeable rise in the use of lancets alongside other tools for managing diabetes. The government of Canada is planning to initiate a fund to manage and support access to medical devices and supplies such as glucometers, test strips, and lancets to assist diabetic patients in managing and monitoring their blood sugar levels.

Safety Lancets are Expected to Dominate the Global Lancets Market

There are multiple reasons behind the growth of safety lancets; it is anticipated to gain considerable traction in the coming years due to increasing cases of chronic illnesses (for example, diabetes, hematoma, anemia), increasing need for home-based medical services and general awareness concerning the advantages associated with the use of safety lancets. All these act as drivers for its rapid expansion, while traditional lancets have a minimal edge over it in terms of clinical benefits over safety lancets. Safety lancets are designed with features that help to prevent accidental needle stick injuries, reducing the risk of infection and injury for healthcare professionals and patients. Safety lancets obtain an adequate quantity of blood with a single stick, which helps prevent wastage of strips, keeps costs down, and prevents the need to re-prick your finger. Safety lancets use high speed, offer minimum pain, prevent error, have a comfortable grip, and are ergonomically designed.

In 2021, Owen Mumford Limited introduced Unistik Touch, a high-flow safety lancet. Unistik Touch makes capillary blood sampling easy with its one-touch activation feature. Unistik Touch uses comfort zone technology (CZT) and comes in various sizes to meet blood volume requirements. In order to improve comfort when placed against the sample site during blood drawing, CZT is made up of several elevated pressure points on the patient end of the safety lancet.

Asia-Pacific is Expected to Grow at the Fastest Rate

During the forecast period, there is anticipated to be a significant need for lancets in Asia-Pacific. The rising incidence of chronic illnesses like diabetes mostly drives the demand for lancets in the region. An increase in diabetes incidence has been observed in countries such as China and India, which has increased the need for lancets and blood glucose monitoring devices. The increasing need for lancing devices is also being fueled by the region's expanding diagnostic test pool, as well as advancements in healthcare infrastructure. Furthermore, the demand for lancets to draw blood samples for testing and diagnosis is being driven by the rising prevalence of infectious illnesses in Asia-Pacific, including malaria, dengue, diabetes, and chikungunya. This region's lancet market is also driven by government programs aimed at promoting integrated healthcare systems across urban and rural areas and improving diabetes treatment.

The results of a countrywide survey published by The Lancet Diabetes & Endocrinology journal, 2023, show that 11.4% of Indians have diabetes, while 35.5% and 15.3% of persons have hypertension and prediabetes, respectively.

Future Market Scenario (2024-2031F)

The demand for lancets is expected to witness substantial growth in the future. An important factor behind the significant growth is the rising prevalence of blood disorders and diabetes, coupled with improved lancet technology to improve patient comfort and convenience. Regarding advancements, medical device manufacturers are prioritizing painless lancing devices that have adjustability on penetration depth by making patients feel better. Continuous Glucose Monitoring (CGM) systems are gaining popularity among diabetic patients. However, lancing devices and lancets remain essential for periodic calibration and confirmatory blood glucose measurements. While CGM systems provide real-time glucose readings and trend information, they still require fingerstick calibrations for accuracy, thereby sustaining the demand for lancets.

Key Players Landscape and Outlook

Several medical device companies like HTL-Strefa S.A., Terumo Medical Corporation, Becton Dickinson and Company, F.Hoffman-La Roche AG, B.Braun SE, Abbott Laboratories, Owen Mumford Ltd., Arkray Inc, Bayer AG and Medline Industries, LP are flourishing in the global lancets market by planning and adopting new strategies. They comply with new strategic initiatives for lancets to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.

Leading multinational medical device company BD (Becton, Dickinson, and Company) announced in 2022 that it successfully spun out Embecta Corp. (beta), which currently owns BD's former diabetes care division and is among the biggest diabetes care companies globally. Grow, Simplify, and Empower - BD's three strategic pillars-are the foundation of the company's BD 2025 plan, which the spinoff can see of embecta. The goal of the spinoff was to split into two distinct businesses that would provide BD stockholders with significant long-term value and improved strategic, operational, and financial attributes.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Lancets Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Safety Lancets
      • 4.2.1.2. Standard Lancets
      • 4.2.1.3. Specialty Lancets
      • 4.2.1.4. Others
    • 4.2.2. By Application
      • 4.2.2.1. Glucose Testing
      • 4.2.2.2. Hemoglobin Testing
      • 4.2.2.3. Cholesterol Testing
      • 4.2.2.4. Coagulation Testing
      • 4.2.2.5. Others
    • 4.2.3. By Age Group
      • 4.2.3.1. Adults
      • 4.2.3.2. Pediatric
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Clinics
      • 4.2.4.3. Diagnostic Centers
      • 4.2.4.4. Home Care Settings
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Application
    • 4.3.3. By Age Group
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Lancets Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Safety Lancets
      • 5.2.1.2. Standard Lancets
      • 5.2.1.3. Specialty Lancets
      • 5.2.1.4. Others
    • 5.2.2. By Application
      • 5.2.2.1. Glucose Testing
      • 5.2.2.2. Hemoglobin Testing
      • 5.2.2.3. Cholesterol Testing
      • 5.2.2.4. Coagulation Testing
      • 5.2.2.5. Others
    • 5.2.3. By Age Group
      • 5.2.3.1. Adults
      • 5.2.3.2. Pediatric
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Clinics
      • 5.2.4.3. Diagnostic Centers
      • 5.2.4.4. Home Care Settings
      • 5.2.4.5. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Lancets Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Safety Lancets
          • 5.3.1.2.1.2. Standard Lancets
          • 5.3.1.2.1.3. Specialty Lancets
          • 5.3.1.2.1.4. Others
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Glucose Testing
          • 5.3.1.2.2.2. Hemoglobin Testing
          • 5.3.1.2.2.3. Cholesterol Testing
          • 5.3.1.2.2.4. Coagulation Testing
          • 5.3.1.2.2.5. Others
        • 5.3.1.2.3. By Age Group
          • 5.3.1.2.3.1. Adults
          • 5.3.1.2.3.2. Pediatric
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals
          • 5.3.1.2.4.2. Clinics
          • 5.3.1.2.4.3. Diagnostic Centers
          • 5.3.1.2.4.4. Home Care Settings
          • 5.3.1.2.4.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Lancets Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Lancets Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Lancets Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Lancets Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Clinical Trials
  • 17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. HTL-Strefa S.A.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Terumo Medical Corporation
    • 20.3.3. Becton Dickinson and Company
    • 20.3.4. F.Hoffman-La Roche AG
    • 20.3.5. B.Braun SE
    • 20.3.6. Abbott Laboratories
    • 20.3.7. Owen Mumford Ltd.
    • 20.3.8. Arkray Inc
    • 20.3.9. Bayer AG
    • 20.3.10. Medline Industries, LP

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer